Maxygen Inc (NASDAQ:MAXY)
During the Trading Day
| 2.38 |  +0.02 / +0.85% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 2.38 |  0.00 / 0.00% |
Volume: 2.2K |
Latest MAXY News | Press Releases
No recent news for Maxygen Inc.
Today’s Trading
| Previous close | 2.36 |
| Today’s open | 2.35 |
| Day’s range | 2.35 - 2.40 |
| Volume | 21,195 |
| Average volume (3 months) | 76,080 |
| Market cap | $65.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -59.44% |
| Earnings growth (this year) | -143.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5,249.55% |
| P/E ratio | 3.2 |
| Price/Sales | 2.24 |
| Price/Book | 0.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARWRArrowhead Research C... | -0.03 | -1.38% |
| STEMStemCells Inc | +0.01 | +0.53% |
| AEZSAEterna Zentaris Inc | -0.03 | -1.46% |
| CRLRFCrailar Technologies... | -0.02 | -1.71% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | $20.1M |
| Net profit margin | 67.05% |
Profile
Sector Health Technology |
Industry Biotechnology |
Director, Chief Executive & Financial Officer James R. Sulat, MBA |
Senior Vice President Grant Yonehiro, MBA, CFA |
Corporate headquarters San Mateo, California |
Forecasts
